IDegLira for the real-world treatment of type 2 diabetes in Italy: protocol and interim results from the REX observational study
GP Fadini, R Buzzetti, MR Fittipaldi, F D'Incau… - Diabetes Therapy, 2022 - Springer
Introduction IDegLira was shown to maintain glycemic control while reducing risk of
hypoglycemia and body weight gain. The REX study was designed to generate real-world …
hypoglycemia and body weight gain. The REX study was designed to generate real-world …